Given the challenges public sector organisations face with excessive paperwork, Intelligent Document Processing (IDP) offers a solution to enhance efficiency by automating document capture, extraction, classification, and decision-making.
The FDA have labelled the Johnson & Johnson COVID vaccine as a possible cause of Guillain-Barré syndrome - an extremely rare side effect that can potentially cause nerve damage.
Adam Mayer, Senior Manager, Qlik, discusses the impact that data analytics has had on policing and on how the Avon and Somerset Police have been at the forefront.
A new study by Hiroshima university uses satellite imagery to predict underwater volcano eruptions - using sea discolouration as a measurement of looming danger.
Davide Villa, business development director for EMEAI at Western Digital, discusses the data storage challenges in the healthcare industry and how they can be addressed.
An Australian team found that antibodies created by infection with the virus are not effective against COVID variants - suggesting that vaccination gives stronger protection.
The Lambda variant, originating in Peru, has been found in 32 countries - but for the moment, it remains classified as a less threatening Variant of Interest.
SAGE say the UK Governments' plans to lift all social distancing measures on 19 July are too much - they believe a rise in infections will increase ethnic minority COVID deaths.
While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.
A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.
A study on New York City neighbourhoods found that "neighbourhood disadvantage", a mix of inequality measurements, is connected to a higher rate of COVID-19 cases.
Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.
